Ethos Technologies Inc. - Class A (LIFE) earnings
Quarterly and annual LIFE reports and results, each read against the price at its own news timestamp. Back to the LIFE overview →
10 measured LIFE earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Ethos to Announce Third Quarter 2026 Financial Results on November 2, 2026 | Press release | +4.42% | +6.68% | |
| Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026 | Press release | +0.58% | +0.57% | |
| Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026 | Press release | +0.38% | +1.67% | |
| Form 10-Q aTYR PHARMA INC For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q aTYR PHARMA INC For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update | Press release | +0.00% | +0.63% | |
| Form 10-Q aTYR PHARMA INC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.63% | |
| Form 10-K aTYR PHARMA INC For: Dec 31 | SEC filing · Form 10-K | +6.79% | +22.84% | |
| aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update | Press release | -1.72% | -3.45% | |
| Form 10-Q aTYR PHARMA INC For: Sep 30 | SEC filing · Form 10-Q | -1.72% | -3.45% |
Keep exploring
More LIFE: analyst actions → · SEC filings → · LIFE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
| Intercept Pharmaceuticals, Inc. (ICPT) | 83 | +0.09% | 68% |
| COLOPLAST AS SP/ADR (CLPBY) | 82 | +0.13% | 59% |
| BASILEA PHARM AG AKT SHS (BPMUF) | 81 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.